Technology
Health
Medical

NuVasive

$58.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.07%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell NuVasive and other stocks, options, ETFs, and crypto commission-free!

About NUVA

NuVasive, Inc. engages in the development of minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. It offers cervical and spine fusion surgery, cervical plating, and posterior fixation products. Read More The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA.

Employees
2,600
Headquarters
San Diego, California
Founded
1997
Market Cap
3.01B
Price-Earnings Ratio
62.47
Dividend Yield
0.00
Average Volume
264.50K
High Today
$58.68
Low Today
$57.76
Open Price
$57.97
Volume
202.87K
52 Week High
$72.41
52 Week Low
$43.51

Collections

Technology
Health
Medical
US
North America

NUVA News

Seeking AlphaJun 21

NuVasive Is On A Better Path, But Remains A 'Show Me' Story

35
Yahoo FinanceJun 20

Here’s What Hedge Funds Think About NuVasive, Inc.

59
Yahoo FinanceJun 20

Was NuVasive, Inc.'s Earnings Growth Better Than The Industry's?

3

NUVA Earnings

$0.39
$0.49
$0.59
$0.69
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Jul 30, After Hours

More NUVA News

Yahoo FinanceJun 17

NuVasive Expands Advanced Materials Science™ Portfolio with Launch of Porous Titanium Spine Implant for Transforaminal Lumbar Interbody Fusion

0
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.